Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - beclometasondipropionat, formoterolfumarat dihydrat - inhalationspulver - 200+6 mikrog./dosis

Danimarka - Daniż - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 7,2 g/l glyphosat

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

novo nordisk a/s - estradiolhemihydrat, norethisteronacetat - filmovertrukne tabletter

Danimarka - Daniż - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 450 g/l glyphosat

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - alfacalcidol - kapsler, bløde - 0,5 mikrogram

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - aciclovir - tabletter - 400 mg

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - immunosuppressiva - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Danimarka - Daniż - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat